Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SalvaRx

PUBLIC STATUS
SALV STOCK SYMBOL
2 INVESTMENTS
Description

Researcher and developer of drugs. The company engages in research and development of drugs and other related pharmaceutical products to fight cancer and improve the immune system.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
LON
Primary Office
  • British Virgin Islands
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SalvaRx’s full profile, request a free trial.

SalvaRx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore SalvaRx‘s full profile, request access.

Request full access to PitchBook

SalvaRx Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000 20-Mar-2016 000000000000000000 Energy Exploration
iOx Therapeutics Merger/Acquisition Drug Discovery
To view this company’s complete investment and acquisition history, request access »

SalvaRx Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore SalvaRx‘s full profile, request access.

Request full access to PitchBook

SalvaRx Executive Team (2)

Name Title Board
Seat
Contact
Info
Ian Walters Chief Executive Officer
Jim Mellon Executive